


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:05:23Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406593" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406593</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>bmcpcnc</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Pregnancy Childbirth</journal-id><journal-id journal-id-type="iso-abbrev">BMC Pregnancy Childbirth</journal-id><journal-id journal-id-type="pmc-domain-id">61</journal-id><journal-id journal-id-type="pmc-domain">bmcpcnc</journal-id><journal-title-group><journal-title>BMC Pregnancy and Childbirth</journal-title></journal-title-group><issn pub-type="epub">1471-2393</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406593</article-id><article-id pub-id-type="pmcid-ver">PMC12406593.1</article-id><article-id pub-id-type="pmcaid">12406593</article-id><article-id pub-id-type="pmcaiid">12406593</article-id><article-id pub-id-type="pmid">40898059</article-id><article-id pub-id-type="doi">10.1186/s12884-025-08066-1</article-id><article-id pub-id-type="publisher-id">8066</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>The development and validation of postpartum hemorrhage prediction models for pregnancies with placenta previa totalis based on coagulation function indexes: a retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Hong</surname><given-names initials="S">Shibin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Liu</surname><given-names initials="C">Chang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Kang</surname><given-names initials="X">Xin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lio</surname><given-names initials="KU">Ka U.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Le</surname><given-names initials="Y">Yiping</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="T">Ting</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shi</surname><given-names initials="H">Haoting</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Dai</surname><given-names initials="L">Lan</given-names></name><address><email>delta496@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Di</surname><given-names initials="W">Wen</given-names></name><address><email>diwen163@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="N">Ning</given-names></name><address><email>ningning1723@126.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220qvk04</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Department of Obstetrics and Gynecology, Renji Hospital, </institution><institution>Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>160 Pujian Road, Pudong New District, Shanghai, 200127 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220qvk04</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital, </institution><institution>Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>160 Pujian Road, Shanghai, 200127 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00kx1jb78</institution-id><institution-id institution-id-type="GRID">grid.264727.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2248 3398</institution-id><institution>Department of Medicine, Temple University Hospital, </institution><institution>Lewis Katz School of Medicine at Temple University, </institution></institution-wrap>3401 N Broad St, Philadelphia, PA 19140 USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01x48j266</institution-id><institution-id institution-id-type="GRID">grid.502812.c</institution-id><institution>Department of Obstetrics and Gynecology, </institution><institution>Hainan Women and Children&#8217;s Medical Center, </institution></institution-wrap>Changbin Road, Haikou City, 570312 Hainan Province China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220qvk04</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, </institution><institution>Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>No.197 Ruijin er Rd, Shanghai, 200025 China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">478341</issue-id><elocation-id>925</elocation-id><history><date date-type="received"><day>16</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="12884_2025_Article_8066.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The objective of this study is to establish and validate models that can accurately predict postpartum hemorrhage (PPH) in women with placenta previa totalis prior to undertaking cesarean delivery.</p></sec><sec><title>Methods</title><p id="Par2">A retrospective cohort study was conducted on 306 pregnancies with placenta previa totalis delivered between January 2011 and June 2022. The pregnancies were classified into two groups, PPH group and non-PPH group, based on bleeding volume and red blood cell transfusion. Clinical features and pre-operative coagulation function indexes were recorded. The entire cohort was randomly divided into a development cohort (n&#8201;=&#8201;214) and a test cohort (n&#8201;=&#8201;92). Least absolute shrinkage and selection operator (LASSO) was implemented to select significant predictors, followed by step-wise logistic regression analysis to build the prediction model. Additionally, machine learning-based models were compared with the proposed model.</p></sec><sec><title>Results</title><p id="Par3">Among 306 participants, 115 (53.74%) and 50 (54.35%) cases of PPH were observed in the development and test cohorts, respectively. The LASSO-Logistic regression model incorporated preoperative serum fibrinogen level, history of prior cesarean delivery and history of antepartum bleeding as predictors. The model yielded an area under the receiver operating characteristic (ROC) curve of 0.721 (95% CI 0.652&#8211;0.790) in the development cohort and 0.706 (95% CI 0.600&#8211;0.813) in the test cohort. Additionally, the model demonstrated a specificity of 70.7% (95% CI 61.7&#8211;79.7%) and a positive predictive value of 72.1% (95% CI 63.5&#8211;80.7%) for distinguishing between PPH and non-PPH cases. The LASSO-Logistic regression model outperformed the machine learning based model in the test cohort, confirming its efficiency in predicting PPH in patients with placenta previa totalis.</p></sec><sec><title>Conclusions</title><p id="Par4">This study successfully developed and validated a LASSO-Logistic regression model incorporating coagulation indicators to predict PPH in patients with placenta previa totalis. Further large-scale prospective studies are warranted to externally validate the three-variate-based model and assess its practical application in real-time practice.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12884-025-08066-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Placenta previa</kwd><kwd>Postpartum hemorrhage</kwd><kwd>Prediction model</kwd><kwd>Coagulation function indexes</kwd><kwd>Machine learning</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82201846</award-id><principal-award-recipient><name name-style="western"><surname>Liu</surname><given-names>Chang</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Natural Science Foundation of Science and Technology Commission of Shanghai Municipality</institution></funding-source><award-id>22ZR1438700</award-id><principal-award-recipient><name name-style="western"><surname>Zhang</surname><given-names>Ning</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100017950</institution-id><institution>Shanghai Municipal Health Commission</institution></institution-wrap></funding-source><award-id>20224Y0019</award-id><principal-award-recipient><name name-style="western"><surname>Zhang</surname><given-names>Ning</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par34">It is well known that postpartum hemorrhage is the leading preventable cause of maternal mortality worldwide [<xref ref-type="bibr" rid="CR1">1</xref>] and accounts for 20% of maternal deaths in in developing region [<xref ref-type="bibr" rid="CR2">2</xref>]. In the United States (2014), the rate of postpartum hemorrhage requiring blood transfusion was approximately 40 per 10,000 deliveries. Postpartum hemorrhage has been defined as a cumulative blood loss of 1000&#160;ml or more or blood loss associated with signs or symptoms of hypovolemia. And identification of patients at risk for postpartum hemorrhage have been shown to decrease maternal morbidity and mortality [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par35">Pregnant women with placenta previa have a high risk of experiencing postpartum hemorrhage. Placenta previa is characterized by the complete or partial coverage of the internal cervical orifice by the placenta. Complete placenta previa, also known as placenta previa totalis (PPT), is associated with vaginal bleeding in late pregnancy or the postpartum period and can lead to premature delivery, blood transfusion and hysterectomy. The combination of placenta previa and placenta accreta spectrum (PAS) can result in uncontrollable postpartum hemorrhage [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par36">The majority of deaths related to placenta previa could be prevented through timely prevention and treatment [<xref ref-type="bibr" rid="CR4">4</xref>]. For pregnant women with placenta previa who are at high risk of postpartum hemorrhage, the probability and amount of blood loss can be significantly reduced through preventive interventions [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Combined interventions such as balloon occlusion and uterine artery embolization have been shown to reduce blood loss in patients with high-risk placenta previa during cesarean delivery [<xref ref-type="bibr" rid="CR5">5</xref>]. Preoperative specific interventions have the potential to decrease the risk of intraoperative bleeding and improve outcomes for patients with PPT.</p><p id="Par37">Accurate identification of pregnant women with placenta previa who are at a high probability of experiencing postpartum hemorrhage is crucial for prompt intervention and reducing maternal and infant mortality. Multiple studies have demonstrated risk factors for postpartum hemorrhage and developed prediction nomograms or scoring models based on ultrasonic imaging or magnetic resonance imaging (MRI) characteristics in patients with PP or PAS [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. However, ultrasound evaluation of placenta previa requires the expertise of an experienced sonographer, and MRI is expensive and time&#8208;consuming making it unsuitable for routine clinical examination. Therefore, we aimed to investigate and identify risk factors, including clinical characteristics and coagulation function indexes, in order to develop and validate a simple model for predicting postpartum hemorrhage in women with PPT before cesarean delivery.</p></sec><sec id="Sec2"><title>Method and material</title><sec id="Sec3"><title>Ethical approval</title><p id="Par38">This study was approved by the Ethics Committee of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (LY2022-055-B). All procedures were performed in compliance with the ethical standards of the Ethics Committee and in accordance with the Helsinki Declaration of 1975, as revised in 2008. The requirement for written informed consent was waived for this study.</p></sec><sec id="Sec4"><title>Study population</title><p id="Par39">This retrospective cohort study was conducted at the Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, and included pregnancies with PPT between January 2011 and June 2021. Clinical data extracted from medical records were included based on the following criteria: (1) placenta previa totalis identified by color doppler ultrasonography before delivery; (2) gestational age of more than 28&#160;weeks; (3) this cesarean delivery at our institution. Exclusion criteria included: (1) incomplete clinical data; (2) preoperative stillbirth; (3) patients with abnormal coagulation disease. The medical records of all enrolled patients were independently reviewed, and data regarding baseline clinical characteristics, pregnancy-related complications, delivery and outcomes were collected and analyzed.</p><p id="Par40">The diagnosis of PPT was confirmed when the placenta completely covered the internal orifice of the cervix after 28&#160;weeks gestation. Transabdominal and transvaginal ultrasonography were performed by experienced ultrasound obstetricians less than one week prior to cesarean delivery to verify the exact location of the placenta.</p><p id="Par41">Postpartum hemorrhage was chosen as the primary outcome of the study, which was defined as blood loss of&#8201;&#8805;&#8201;1000&#160;mL within 24&#160;h of childbirth or a transfusion of red blood cells (RBCs) of&#8201;&#8805;&#8201;4 units after delivery [<xref ref-type="bibr" rid="CR4">4</xref>]. Intraoperative blood loss was evaluated using volumetric and weighing methods and was recorded from the beginning of the skin incision for caesarean section.</p><p id="Par42">During the study period, a total of 346 patients were identified, of whom 40 patients were excluded based on the exclusion criteria. The final analysis included 306 patients who met the study criteria. Based on the criteria of blood loss and RBCs transfusion, 150 patients had blood loss&#8201;&#8805;&#8201;1000&#160;mL and 144 patients had RBCs transfusion&#8201;&#8805;&#8201;4 units. These patients were classified into the postpartum hemorrhage group (PPH) comprising 165 patients and the non-postpartum hemorrhage group (non-PPH) comprising 141 patients with bleeding less than 1000&#160;mL and RBCs transfusion less than 4 units.</p><p id="Par43">A summary of the research procedure is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>The summary of the research procedure; <bold>A</bold> The process of inclusion criteria, exclusion criteria and grouping of the patients; <bold>B</bold> Model development and validation in LASSO-Logistic regression. <bold>C</bold> Model training and validation based on machine learning</p></caption><graphic id="d33e505" position="float" orientation="portrait" xlink:href="12884_2025_8066_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec5"><title>Data collection</title><p id="Par44">Numerous factors associated with PPH have been reported in the literature [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>], including maternal age, gravidity, parity, gestational age, in-vitro fertilization (IVF), history of cesarean delivery, body mass index (BMI) at delivery, antepartum bleeding, preoperative hemoglobin, gestational diabetes mellitus, emergency cesarean delivery. The risk assessment studies for PPH are shown in Table <xref rid="MOESM1" ref-type="media">S1</xref>.</p><p id="Par45">For our analysis, we selected potential risk factors based on a literature review. The baseline characteristics included maternal age, gravidity, parity, IVF, twin pregnancy, gestational weeks at delivery, BMI at delivery, previous cesarean delivery, and previous uterine body surgery including myomectomy, hysteroscopy and uterine curettage. Pregnancy complications, including diabetes mellitus, hypertension and autoimmune disease, were also considered. Perioperative characteristics included emergency cesarean delivery, preoperative mean arterial pressure, antepartum hemorrhage, serum levels of platelet count (PLT), D-Dimer, activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen (FIB) and preoperative hemoglobin, neonatal weight, units of transfused packed RBCs, intraoperative blood loss, hemoglobin one day after cesarean delivery, prophylactic balloon occlusion (PBO), uterine artery embolization, uterine artery ligation, intrauterine balloon tamponade, hysterectomy, postoperative hospital stay and transfer to neonatology.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par46">We analyzed discrete data using the &#967;2-test or Fisher&#8217;s exact test and continuous variables using the Student&#8217;s T-test and the Mann&#8211;Whitney U-test as appropriate, where P&#8201;&lt;&#8201;0.05 was used as the criteria for variable inclusion in the predictor selection using the least absolute shrinkage and selection operator (LASSO) with tenfold cross validation. Subsequently, stepwise logistic regression analysis was used to develop the risk prediction model (LASSO-Logistic model) in the development cohort.</p><p id="Par47">Meanwhile, we applied a variety of machining learning methods in the dimension reduction process (PCA, PCC), feature selection (ANOVA, RFE, KW, Relief, for 1&#8211;6 variables), and classifier establishment (Linear Regression, LASSO-Linear Regression, Gaussian Process, Linear Discriminant Analysis, Adaboost, Support Vector Machine, Random Forest, Na&#239;ve Bayes, Decision Tree, Auto-Encoder), resulting a total of 480 (2&#8201;&#215;&#8201;4&#8201;&#215;&#8201;6&#8201;&#215;&#8201;10) pipelines [<xref ref-type="bibr" rid="CR18">18</xref>]. The models with the top five highest area under curve (AUC) were selected and compared with the primary model (LASSO-Logistic model). We examined the primary endpoint, i.e., AUC, specificity and positive predictive value (PPV) for the models in both cohorts. Cut-off points were determined according to the largest Youden index and weighted Youden&#8217;s index for each pipeline, respectively. The maximum number of predictors predefined for the LASSO-Logistic and machine learning-based models was five.</p><p id="Par48">Discriminative power and calibration of high-risk factors were tested through receiver operating characteristic curve and calibration curve analyses (DCA). Decision curve analysis was applied to assess the performance of the predictive models.</p><p id="Par49">All analyses were performed using R statistics software (version 4.2.2). Continuous data were expressed as the mean&#8201;&#177;&#8201;SD or median (IQR) according to the distribution and categorical data were expressed as numbers (percentages). Statistical significance was considered when a two-tailed<italic toggle="yes"> P</italic>-value was less than 0.05.</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Patient characteristics</title><p id="Par50">A total of 306 pregnant women diagnosed with PPT were included in our study. The baseline and perioperative characteristics of the patient population are summarized in Tables&#160;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>, respectively. Among the 306 patients, the mean maternal age was 33.35&#8201;&#177;&#8201;4.52&#160;years, the mean BMI was 26.30&#8201;&#177;&#8201;3.48&#160;kg/m<sup>2</sup>, the mean gestational age was 35.61&#8201;&#177;&#8201;1.79&#160;weeks, and 46 (15.03%) patients conceived through assisted reproduction. Regarding to previous surgical history, 155 (50.65%) patients had previous cesarean delivery, 10 (3.27%) had undergone myomectomy, and 191 (62.42%) had undergone other uterine cavity surgeries, including uterine curettage or/and hysteroscopy. Among the 151 patients without a prior cesarean history, 56 (37.09%) developed postpartum hemorrhage during delivery. For women with one prior cesarean, the incidence was 69.57% (96/138), and for those with two or more cesarean deliveries, it rose to 76.47% (13/17).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>The basic characteristics of patient population</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Total<break/>n&#8201;=&#8201;306</th><th align="left" colspan="1" rowspan="1">PPH group<break/>n&#8201;=&#8201;165</th><th align="left" colspan="1" rowspan="1">Non-PPH group<break/>n&#8201;=&#8201;141</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1">Maternal age</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean (years), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">33.35&#8201;&#177;&#8201;4.52</td><td align="left" colspan="1" rowspan="1">33.45&#8201;&#177;&#8201;4.26</td><td align="left" colspan="1" rowspan="1">33.24&#8201;&#177;&#8201;4.83</td><td align="left" colspan="1" rowspan="1">0.69</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&lt;&#8201;35, no. (%)</td><td align="left" colspan="1" rowspan="1">184 (60.13)</td><td align="left" colspan="1" rowspan="1">100 (60.61)</td><td align="left" colspan="1" rowspan="1">84 (59.57)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;35&#8211;39, no. (%)</td><td align="left" colspan="1" rowspan="1">97 (31.7)</td><td align="left" colspan="1" rowspan="1">52 (31.52)</td><td align="left" colspan="1" rowspan="1">45 (31.91)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;40, no. (%)</td><td align="left" colspan="1" rowspan="1">25 (8.17)</td><td align="left" colspan="1" rowspan="1">13 (7.88)</td><td align="left" colspan="1" rowspan="1">12 (8.51)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Gravidity</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">3.32&#8201;&#177;&#8201;1.97</td><td align="left" colspan="1" rowspan="1">3.57&#8201;&#177;&#8201;1.96</td><td align="left" colspan="1" rowspan="1">3.02&#8201;&#177;&#8201;1.94</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1, no. (%)</td><td align="left" colspan="1" rowspan="1">49 (16.01)</td><td align="left" colspan="1" rowspan="1">15 (9.09)</td><td align="left" colspan="1" rowspan="1">34 (24.11)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2, no. (%)</td><td align="left" colspan="1" rowspan="1">62 (20.26)</td><td align="left" colspan="1" rowspan="1">33 (20.00)</td><td align="left" colspan="1" rowspan="1">29 (20.57)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;3, no. (%)</td><td align="left" colspan="1" rowspan="1">74 (24.18)</td><td align="left" colspan="1" rowspan="1">41 (24.85)</td><td align="left" colspan="1" rowspan="1">33 (23.40)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;4, no. (%)</td><td align="left" colspan="1" rowspan="1">61 (19.93)</td><td align="left" colspan="1" rowspan="1">40 (24.24)</td><td align="left" colspan="1" rowspan="1">21 (14.89)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;5, no. (%)</td><td align="left" colspan="1" rowspan="1">60 (19.61)</td><td align="left" colspan="1" rowspan="1">36 (21.82)</td><td align="left" colspan="1" rowspan="1">24 (17.02)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Parity</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">0.8&#8201;&#177;&#8201;0.71</td><td align="left" colspan="1" rowspan="1">0.9&#8201;&#177;&#8201;0.64</td><td align="left" colspan="1" rowspan="1">0.69&#8201;&#177;&#8201;0.78</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0, no. (%)</td><td align="left" colspan="1" rowspan="1">108 (35.29)</td><td align="left" colspan="1" rowspan="1">43 (26.06)</td><td align="left" colspan="1" rowspan="1">65 (46.10)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1, no. (%)</td><td align="left" colspan="1" rowspan="1">156 (50.98)</td><td align="left" colspan="1" rowspan="1">96 (58.18)</td><td align="left" colspan="1" rowspan="1">60 (42.55)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;2, no. (%)</td><td align="left" colspan="1" rowspan="1">42 (13.73)</td><td align="left" colspan="1" rowspan="1">26 (15.76)</td><td align="left" colspan="1" rowspan="1">16 (11.35)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">IVF (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">46 (15.03)</td><td align="left" colspan="1" rowspan="1">24 (14.55)</td><td align="left" colspan="1" rowspan="1">22 (15.60)</td><td align="left" colspan="1" rowspan="1">0.87</td></tr><tr><td align="left" colspan="1" rowspan="1">Twin pregnancy (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">8 (2.61)</td><td align="left" colspan="1" rowspan="1">6 (3.64)</td><td align="left" colspan="1" rowspan="1">2 (1.42)</td><td align="left" colspan="1" rowspan="1">0.29</td></tr><tr><td align="left" colspan="1" rowspan="1">Gestational age</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean (weeks), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">35.61&#8201;&#177;&#8201;1.79</td><td align="left" colspan="1" rowspan="1">35.37&#8201;&#177;&#8201;1.86</td><td align="left" colspan="1" rowspan="1">35.89&#8201;&#177;&#8201;1.66</td><td align="left" colspan="1" rowspan="1">0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&lt;&#8201;34, no. (%)</td><td align="left" colspan="1" rowspan="1">52 (16.99)</td><td align="left" colspan="1" rowspan="1">34 (20.61)</td><td align="left" colspan="1" rowspan="1">18 (12.77)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;34 and&#8201;&lt;&#8201;37, no. (%)</td><td align="left" colspan="1" rowspan="1">192 (62.75)</td><td align="left" colspan="1" rowspan="1">103 (62.42)</td><td align="left" colspan="1" rowspan="1">89 (63.12)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;37, no. (%)</td><td align="left" colspan="1" rowspan="1">62 (20.26)</td><td align="left" colspan="1" rowspan="1">28 (16.37)</td><td align="left" colspan="1" rowspan="1">34 (24.11)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Body mass index</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.18</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean (kg/m<sup>2</sup>.), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">26.3&#8201;&#177;&#8201;3.48</td><td align="left" colspan="1" rowspan="1">26.54&#8201;&#177;&#8201;3.48</td><td align="left" colspan="1" rowspan="1">26.01&#8201;&#177;&#8201;3.46</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&lt;&#8201;24, no. (%)</td><td align="left" colspan="1" rowspan="1">74 (24.18)</td><td align="left" colspan="1" rowspan="1">30 (18.18)</td><td align="left" colspan="1" rowspan="1">44 (31.21)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;24&#8211;27.9, no. (%)</td><td align="left" colspan="1" rowspan="1">154 (50.33)</td><td align="left" colspan="1" rowspan="1">94 (56.97)</td><td align="left" colspan="1" rowspan="1">60 (42.55)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;28, no. (%)</td><td align="left" colspan="1" rowspan="1">78 (25.49)</td><td align="left" colspan="1" rowspan="1">41 (24.85)</td><td align="left" colspan="1" rowspan="1">37 (26.24)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Cesarean times (n), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">0.57&#8201;&#177;&#8201;0.62</td><td align="left" colspan="1" rowspan="1">0.74&#8201;&#177;&#8201;0.59</td><td align="left" colspan="1" rowspan="1">0.37&#8201;&#177;&#8201;0.59</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0, no. (%)</td><td align="left" colspan="1" rowspan="1">151 (49.35)</td><td align="left" colspan="1" rowspan="1">56 (33.94)</td><td align="left" colspan="1" rowspan="1">95 (67.37)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1, no. (%)</td><td align="left" colspan="1" rowspan="1">138 (45.10)</td><td align="left" colspan="1" rowspan="1">96 (58.18)</td><td align="left" colspan="1" rowspan="1">42 (29.79)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;2, no. (%)</td><td align="left" colspan="1" rowspan="1">17 (5.55)</td><td align="left" colspan="1" rowspan="1">13 (7.88)</td><td align="left" colspan="1" rowspan="1">4 (2.84)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Previous uterine surgery</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0, no. (%)</td><td align="left" colspan="1" rowspan="1">111 (36.27)</td><td align="left" colspan="1" rowspan="1">47 (28.48)</td><td align="left" colspan="1" rowspan="1">64 (45.39)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1, no. (%)</td><td align="left" colspan="1" rowspan="1">90 (29.41)</td><td align="left" colspan="1" rowspan="1">52 (31.52)</td><td align="left" colspan="1" rowspan="1">38 (26.95)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;2, no. (%)</td><td align="left" colspan="1" rowspan="1">105 (34.41)</td><td align="left" colspan="1" rowspan="1">66 (40.00)</td><td align="left" colspan="1" rowspan="1">39 (27.66)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes mellitus (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">76 (24.84)</td><td align="left" colspan="1" rowspan="1">41 (24.85)</td><td align="left" colspan="1" rowspan="1">35 (24.82)</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">11 (3.59)</td><td align="left" colspan="1" rowspan="1">6 (3.64)</td><td align="left" colspan="1" rowspan="1">5 (3.55)</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Autoimmune disease (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">18 (5.88)</td><td align="left" colspan="1" rowspan="1">6 (3.64)</td><td align="left" colspan="1" rowspan="1">12 (8.51)</td><td align="left" colspan="1" rowspan="1">0.09</td></tr></tbody></table><table-wrap-foot><p>IVF: in-vitro fertilization; PPH: Postpartum hemorrhage; SD: Standard Deviation; no. (%): number (percentage)</p></table-wrap-foot></table-wrap><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>The perioperative characteristics of patient population</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Total<break/>n&#8201;=&#8201;306</th><th align="left" colspan="1" rowspan="1">PPH group<break/>n&#8201;=&#8201;165</th><th align="left" colspan="1" rowspan="1">Non-PPH group<break/>n&#8201;=&#8201;141</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Emergency cesarean (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">80 (26.14)</td><td align="left" colspan="1" rowspan="1">54 (32.73)</td><td align="left" colspan="1" rowspan="1">26 (18.44)</td><td char="." align="char" colspan="1" rowspan="1">0.006</td></tr><tr><td align="left" colspan="1" rowspan="1">Mean arterial pressure (mmHg), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">81.26&#8201;&#177;&#8201;10.14</td><td align="left" colspan="1" rowspan="1">90.04&#8201;&#177;&#8201;12.00</td><td align="left" colspan="1" rowspan="1">91.26&#8201;&#177;&#8201;8.48</td><td char="." align="char" colspan="1" rowspan="1">0.99</td></tr><tr><td align="left" colspan="1" rowspan="1">Antepartum hemorrhage (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">141 (46.08)</td><td align="left" colspan="1" rowspan="1">91 (55.15)</td><td align="left" colspan="1" rowspan="1">50 (35.46)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">PLT (10^9/L), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">193.98&#8201;&#177;&#8201;55.39</td><td align="left" colspan="1" rowspan="1">186.63&#8201;&#177;&#8201;49.32</td><td align="left" colspan="1" rowspan="1">202.59&#8201;&#177;&#8201;60.80</td><td char="." align="char" colspan="1" rowspan="1">0.012</td></tr><tr><td align="left" colspan="1" rowspan="1">D-Dimer (DDU ug/mL), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">1.23&#8201;&#177;&#8201;2.02</td><td align="left" colspan="1" rowspan="1">1.31&#8201;&#177;&#8201;1.60</td><td align="left" colspan="1" rowspan="1">1.14&#8201;&#177;&#8201;2.44</td><td char="." align="char" colspan="1" rowspan="1">0.48</td></tr><tr><td align="left" colspan="1" rowspan="1">APTT (s), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">27.36&#8201;&#177;&#8201;2.76</td><td align="left" colspan="1" rowspan="1">27.77&#8201;&#177;&#8201;3.16</td><td align="left" colspan="1" rowspan="1">26.89&#8201;&#177;&#8201;2.10</td><td char="." align="char" colspan="1" rowspan="1">0.005</td></tr><tr><td align="left" colspan="1" rowspan="1">PT (s), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">10.77&#8201;&#177;&#8201;0.93</td><td align="left" colspan="1" rowspan="1">10.76&#8201;&#177;&#8201;0.98</td><td align="left" colspan="1" rowspan="1">10.78&#8201;&#177;&#8201;0.87</td><td char="." align="char" colspan="1" rowspan="1">0.86</td></tr><tr><td align="left" colspan="1" rowspan="1">TT (s), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">15.51&#8201;&#177;&#8201;1.86</td><td align="left" colspan="1" rowspan="1">15.33&#8201;&#177;&#8201;1.80</td><td align="left" colspan="1" rowspan="1">15.71&#8201;&#177;&#8201;1.92</td><td char="." align="char" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="1" rowspan="1">FIB (g/L), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">4.11&#8201;&#177;&#8201;0.93</td><td align="left" colspan="1" rowspan="1">3.95&#8201;&#177;&#8201;0.93</td><td align="left" colspan="1" rowspan="1">4.3&#8201;&#177;&#8201;0.89</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Preoperative hemoglobin (g/L)</td><td align="left" colspan="1" rowspan="1">111.55&#8201;&#177;&#8201;13.45</td><td align="left" colspan="1" rowspan="1">109.39&#8201;&#177;&#8201;13.31</td><td align="left" colspan="1" rowspan="1">114.09&#8201;&#177;&#8201;13.22</td><td char="." align="char" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">Neonatal weight (g), no. (%) *</td><td align="left" colspan="1" rowspan="1">2664&#8201;&#177;&#8201;504.5</td><td align="left" colspan="1" rowspan="1">2617&#8201;&#177;&#8201;521.4</td><td align="left" colspan="1" rowspan="1">2720&#8201;&#177;&#8201;479.4</td><td char="." align="char" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8201;&lt;&#8201;2000</td><td align="left" colspan="1" rowspan="1">25 (7.96)</td><td align="left" colspan="1" rowspan="1">17 (9.94)</td><td align="left" colspan="1" rowspan="1">8 (5.59)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">2000&#8211;2999</td><td align="left" colspan="1" rowspan="1">217 (69.11)</td><td align="left" colspan="1" rowspan="1">118 (69.01)</td><td align="left" colspan="1" rowspan="1">99 (69.23)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">3000&#8211;3999</td><td align="left" colspan="1" rowspan="1">70 (22.29)</td><td align="left" colspan="1" rowspan="1">35 (20.48)</td><td align="left" colspan="1" rowspan="1">35 (24.48)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;4000</td><td align="left" colspan="1" rowspan="1">2 (0.64)</td><td align="left" colspan="1" rowspan="1">1 (0.57)</td><td align="left" colspan="1" rowspan="1">1 (0.70)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Blood transfusion(mL), median</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1800</td><td align="left" colspan="1" rowspan="1">400</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Blood loss (ml), median</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1200</td><td align="left" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hemoglobin 1&#160;day after CD (g/L)</td><td align="left" colspan="1" rowspan="1">97.03&#8201;&#177;&#8201;16.06</td><td align="left" colspan="1" rowspan="1">90.39&#8201;&#177;&#8201;15.72</td><td align="left" colspan="1" rowspan="1">104.8&#8201;&#177;&#8201;12.64</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Prophylactic balloon occlusion (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">80 (26.14)</td><td align="left" colspan="1" rowspan="1">53 (32.12)</td><td align="left" colspan="1" rowspan="1">27 (19.15)</td><td char="." align="char" colspan="1" rowspan="1">0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">Uterine artery embolization (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">47 (15.36)</td><td align="left" colspan="1" rowspan="1">46 (27.88)</td><td align="left" colspan="1" rowspan="1">1 (0.71)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Uterine arteries ligation (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">41 (13.40)</td><td align="left" colspan="1" rowspan="1">34 (20.61)</td><td align="left" colspan="1" rowspan="1">7 (4.96)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Intrauterine balloon tamponade (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">24 (7.84)</td><td align="left" colspan="1" rowspan="1">16 (9.70)</td><td align="left" colspan="1" rowspan="1">8 (5.67)</td><td char="." align="char" colspan="1" rowspan="1">0.21</td></tr><tr><td align="left" colspan="1" rowspan="1">Hysterectomy (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">13 (4.25)</td><td align="left" colspan="1" rowspan="1">13 (7.88)</td><td align="left" colspan="1" rowspan="1">0</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hospital days (days), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">5.52&#8201;&#177;&#8201;2.25</td><td align="left" colspan="1" rowspan="1">6.36&#8201;&#177;&#8201;2.63</td><td align="left" colspan="1" rowspan="1">4.54&#8201;&#177;&#8201;1.12</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Neonatal transfer (yes), no. (%)</td><td align="left" colspan="1" rowspan="1">95 (31.05)</td><td align="left" colspan="1" rowspan="1">65 (39.39)</td><td align="left" colspan="1" rowspan="1">30 (21.28)</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr></tbody></table><table-wrap-foot><p>*There are eight twins, a total of 314 babies</p><p>PLT: Platelet count; APTT: Activated partial thromboplastin time; PT: Prothrombin time; TT: Thrombin time; FIB: Fibrinogen; CD: Cesarean Delivery; SD: Standard Deviation; no. (%): number (percentage)</p></table-wrap-foot></table-wrap></p><p id="Par51">Regarding the peripartum characteristics of the included 306 patients, 254 (83%) patients delivered after 34th gestational weeks and 62 (20.26%) patients delivered after 37&#160;weeks. 80 (26.14%) patients experienced an emergency cesarean delivery, and 13 patients (4.25%) required hysterectomy due to pernicious hemorrhage. Furthermore, 95 (30.25%) newborns were referred to the neonatal intensive care unit (NICU) due to low birth weight and respiratory distress.</p><p id="Par52">Based on blood loss and transfusion of RBCs, 165 patients were included in the PPH group and 141 patients in the non-PPH group. The mean intraoperative blood loss was significantly higher in the PPH group (2567&#160;ml) compared to the non-PPH group (465&#160;ml) (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05). Statistically significant differences (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05) were observed between the PPH group and the non-PPH group in terms of gravidity, parity, number of prior cesarean deliveries, emergency cesarean, antepartum hemorrhage, PLT, APTT, FIB and preoperative hemoglobin. As expected, the PPH group showed significantly higher rates of auxiliary surgical interventions, including prophylactic balloon occlusion of the internal iliac artery (53/165 vs 17/141), uterine artery embolization (46/165 vs 1/141) and uterine artery ligation (34/165 vs 7/141), as well as a higher rate of hysterectomy (13/165 vs 0/141) and longer postoperative hospital stay (p&#8201;&lt;&#8201;0.05). Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref> provide a comparison of baseline characteristics and pregnancy outcome variables between the PPH group and the non-PPH group.</p></sec><sec id="Sec9"><title>A LASSO-logistic risk prediction model and nomogram of postpartum hemorrhage</title><p id="Par53">The patients were randomly divided into development and test cohorts in a 7:3 ratio. The development cohort consisted of 214 patients (70%), while the test cohort included 92 patients (30%). The<italic toggle="yes"> P</italic>-values for all variables between the development and test cohort were over 0.05, suggesting no significant difference in population characteristics between the two sets. The clinical characteristics of the development and test cohorts are shown in Table <xref rid="MOESM1" ref-type="media">S2</xref>.</p><p id="Par54">There were statistically significant differences in gravidity, parity, number of prior cesarean deliveries, previous uterine surgery, immune disease, gestational age, antepartum bleeding, emergency cesarean, PLT, D-Dimer, APTT, FIB, and hemoglobin (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05) between the PPH group and non-PPH group in development cohort (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>, Table <xref rid="MOESM1" ref-type="media">S3</xref>). After predictor selection by LASSO analysis (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A, B), the prediction model included three predictors: number of prior cesarean deliveries, FIB, and antepartum bleeding. These three factors were fitted into a stepwise logistic regression model. The model with all three variables yielded the lowest Akaike information criterion (AIC) of 272.24 and the largest area under the ROC curve of 0.721(95% CI, 0.652&#8211;0.790) and was selected as the final model (Table <xref rid="MOESM1" ref-type="media">S4</xref>).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Characteristics with statistically significant differences in development cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">PPH<break/>(N&#8201;=&#8201;115)</th><th align="left" colspan="1" rowspan="1">Non-PPH<break/>(N&#8201;=&#8201;99)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> Value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">PLT, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">185&#8201;&#177;&#8201;48.6</td><td align="left" colspan="1" rowspan="1">204&#8201;&#177;&#8201;57.9</td><td char="." align="char" colspan="1" rowspan="1">0.012</td></tr><tr><td align="left" colspan="1" rowspan="1">D-Dimer, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">1.25&#8201;&#177;&#8201;1.07</td><td align="left" colspan="1" rowspan="1">0.93&#8201;&#177;&#8201;0.68</td><td char="." align="char" colspan="1" rowspan="1">0.009</td></tr><tr><td align="left" colspan="1" rowspan="1">APTT, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">27.9&#8201;&#177;&#8201;3.27</td><td align="left" colspan="1" rowspan="1">26.9&#8201;&#177;&#8201;2.21</td><td char="." align="char" colspan="1" rowspan="1">0.015</td></tr><tr><td align="left" colspan="1" rowspan="1">FIB, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">3.98&#8201;&#177;&#8201;0.89</td><td align="left" colspan="1" rowspan="1">4.34&#8201;&#177;&#8201;0.93</td><td char="." align="char" colspan="1" rowspan="1">0.004</td></tr><tr><td align="left" colspan="1" rowspan="1">Hemoglobin, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">109&#8201;&#177;&#8201;12.4</td><td align="left" colspan="1" rowspan="1">114&#8201;&#177;&#8201;13.7</td><td char="." align="char" colspan="1" rowspan="1">0.008</td></tr><tr><td align="left" colspan="1" rowspan="1">Gravidity, no. (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td align="left" colspan="1" rowspan="1">6 (5.22)</td><td align="left" colspan="1" rowspan="1">24 (24.2)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2</td><td align="left" colspan="1" rowspan="1">23 (20.0)</td><td align="left" colspan="1" rowspan="1">22 (22.2)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;3</td><td align="left" colspan="1" rowspan="1">31 (27.0)</td><td align="left" colspan="1" rowspan="1">23 (23.2)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;4</td><td align="left" colspan="1" rowspan="1">30 (26.1)</td><td align="left" colspan="1" rowspan="1">16 (16.2)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;5</td><td align="left" colspan="1" rowspan="1">25 (21.7)</td><td align="left" colspan="1" rowspan="1">14 (14.1)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Parity, no. (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0</td><td align="left" colspan="1" rowspan="1">28 (24.3)</td><td align="left" colspan="1" rowspan="1">47 (47.5)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td align="left" colspan="1" rowspan="1">66 (57.4)</td><td align="left" colspan="1" rowspan="1">41 (41.4)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;2</td><td align="left" colspan="1" rowspan="1">21 (18.3)</td><td align="left" colspan="1" rowspan="1">11 (11.1)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">CD, no. (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0</td><td align="left" colspan="1" rowspan="1">39 (33.9)</td><td align="left" colspan="1" rowspan="1">64 (64.6)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td align="left" colspan="1" rowspan="1">66 (57.4)</td><td align="left" colspan="1" rowspan="1">31 (31.3)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;2</td><td align="left" colspan="1" rowspan="1">10 (8.70)</td><td align="left" colspan="1" rowspan="1">4 (4.04)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Previous uterine surgery*, no. (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;0</td><td align="left" colspan="1" rowspan="1">27 (23.5)</td><td align="left" colspan="1" rowspan="1">47 (47.5)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td align="left" colspan="1" rowspan="1">42 (36.5)</td><td align="left" colspan="1" rowspan="1">24 (24.2)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;2</td><td align="left" colspan="1" rowspan="1">46 (40.0)</td><td align="left" colspan="1" rowspan="1">28 (28.3)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Immune disease, no. (%)</td><td align="left" colspan="1" rowspan="1">3 (2.61)</td><td align="left" colspan="1" rowspan="1">11 (11.1)</td><td char="." align="char" colspan="1" rowspan="1">0.026</td></tr><tr><td align="left" colspan="1" rowspan="1">Gestational age, mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">35.3&#8201;&#177;&#8201;2.02</td><td align="left" colspan="1" rowspan="1">35.9&#8201;&#177;&#8201;1.75</td><td char="." align="char" colspan="1" rowspan="1">0.007</td></tr><tr><td align="left" colspan="1" rowspan="1">Antepartum bleeding, no. (%)</td><td align="left" colspan="1" rowspan="1">70 (60.9)</td><td align="left" colspan="1" rowspan="1">36 (36.4%)</td><td char="." align="char" colspan="1" rowspan="1">0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Emergency CD, no. (%)</td><td align="left" colspan="1" rowspan="1">38 (33.0%)</td><td align="left" colspan="1" rowspan="1">18 (18.2)</td><td char="." align="char" colspan="1" rowspan="1">0.021</td></tr></tbody></table><table-wrap-foot><p>&#8220;*&#8221; Previous uterine surgery including uterine cavity and uterine body operation, such as vacuum aspiration, uterine curettage, and myomectomy, only excluding cesarean delivery</p><p>PLT: Platelet count; APTT: Activated partial thromboplastin time; FIB: Fibrinogen; CD: Cesarean delivery; SD: Standard Deviation; no. (%): number (percentage)</p></table-wrap-foot></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Selection of significant parameters in preoperative characteristics variables in the development cohort and definition of linear predictor. <bold>A</bold> The selection process of the optimum value of the parameter &#955; in the Lasso regression model by cross-validation method. The binomial deviance curve was plotted versus log(&#955;) <bold>B</bold> LASSO coefficient profiles of the 13 features. A coefficient profile plot was produced against the log(&#955;) sequence. <bold>C</bold> Nomogram used to predict PPH in patients with placenta previa totalis. <bold>D</bold> The nomogram application of one case (the pregnant woman with a FIB level of 5, a history of one cesarean delivery and antepartum bleeding, and the total point on the nomogram would be 105.4, corresponding to a risk of hemorrhage of 65.58%)</p></caption><graphic id="d33e1595" position="float" orientation="portrait" xlink:href="12884_2025_8066_Fig2_HTML.jpg"/></fig></p><p id="Par55">We constructed a nomogram for clinical application, which represents the risk of postpartum hemorrhage based on three variables (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C). As illustrated in Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C,D, the operational workflow follows a standardized protocol: clinicians input three key parameters into the nomogram's axis&#8212;fibrinogen concentration (FIB), number of prior cesarean delivery (CD), and antenatal hemorrhage status (Bleeding)&#8212;then sum the corresponding points via alignment lines to obtain the total score, which directly correlates with PPH probability on the final axis. For example, for a pregnant woman with a FIB level of 5, a history of one cesarean delivery and antepartum bleeding, the total point on the nomogram would be 105.4, corresponding to a risk of hemorrhage of 65.58% (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>D).</p></sec><sec id="Sec10"><title>Performance of the LASSO-Logistic risk prediction model.</title><p id="Par56">The 3-variable LASSO-Logistic model yielded an AUC of 0.721 (95% CI 0.652&#8211;0.790) and 0.706 (95% CI 0.600&#8211;0.813) in the development and test cohort, respectively, indicating that this model has good discriminant ability (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). By observing the calibration curve, the probability of PPH demonstrated good agreement between prediction and observation in the development cohort (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>A) and test cohort (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>D). The decision curve analysis for the prediction nomogram showed that if the threshold probability of patients and clinicians is between 28 and 80%, using the 3-variable LASSO-Logistic model in the current study to predict PPH adds more benefit than the treat-all-patients scheme or the treat-none scheme (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>B). Clinical impact curve (CIC) analysis was performed to evaluate clinical applicability of risk prediction nomogram, which showed that the LASSO-Logistic model had a superior overall net benefit within the wide and practical ranges of threshold probabilities and impacted patient outcomes (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C,F).<fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p><bold>A</bold> The receiver operating characteristic curve of the LASSO-Logistic model in the development cohort and test cohort. <bold>B</bold> The receiver operating characteristic curve of the LASSO-Logistic model and models based on machine learning algorithm (Top five performance in AUC) in the development cohort. <bold>C</bold> The receiver operating characteristic curve of the LASSO-Logistic model and models based on machine learning algorithm (Top five performance in AUC) in the test cohort</p></caption><graphic id="d33e1642" position="float" orientation="portrait" xlink:href="12884_2025_8066_Fig3_HTML.jpg"/></fig><fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>Calibration curves, decision curve analysis (DCA) and clinical impact curve (CIC) of the LASSO-Logistic prediction model in the development cohort (<bold>A</bold>&#8211;<bold>C</bold>) and test cohort (D/E/F). <bold>A</bold>, <bold>D</bold> Calibration plot for the diagnostic nomogram. The diagonal 45-degree line indicates perfect prediction. <bold>B</bold>, <bold>E</bold> Decision curve analysis for the LASSO-Logistic prediction model. The net benefit calculated by adding true positive and minus the false positive corresponds to the measurement of Y-axis; X-axis represents the threshold probability. <bold>C</bold>, <bold>F</bold> Clinical impact curve of LASSO-Logistic model. The orange curve (number of high-risk individuals) indicates the number of people who are classified as positive (high risk) by the model at each threshold probability; the grey curve (number of high-risk individuals with outcome) is the number of true positives at each threshold probability. CIC visually indicated that nomogram conferred high clinical net benefit and confirmed the clinical value of the LASSO-Logistic model</p></caption><graphic id="d33e1675" position="float" orientation="portrait" xlink:href="12884_2025_8066_Fig4_HTML.jpg"/></fig></p><p id="Par57">The cut-off threshold of the LASSO-Logistic model was determined based on ROC curve analysis. Two operating points (I and II) were identified using the maximum Youden&#8217;s index and the weighted Youden&#8217;s index (1/3*Sensitivity&#8201;+&#8201;2/3*Specificity), respectively, to accurately identify pregnant women with PPH. However, there was no statistical difference in the positive predictive value (PPV), so the operating point based on the weighted Youden&#8217;s index was rejected (Table <xref rid="MOESM1" ref-type="media">S5</xref>). According to the maximum of Youden&#8217;s index, the cut-off threshold was &#8722;&#160;0.660, resulting in a specificity of 70.7%, a positive predictive value of 72.1%, a sensitivity of 65.2%, and a negative predictive value (NPV) of was 65.2%.</p></sec><sec id="Sec11"><title>Model training and validation based on machine learning</title><p id="Par58">We selected the machine learning-based models with top five performance based on AUC (Table <xref rid="MOESM1" ref-type="media">S6</xref> and Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>). The performance of the machine learning-based models was better than that of the LASSO-Logistic model in the development cohort (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>B). However, in the test cohort, the machine learning-based model did not exhibit higher AUC values compared to the LASSO-Logistic model (AUC ranged from 0.649 to 0.683) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>C). The highest AUC was achieved by the model based on PCC, RFE and logistic regression (AUC, 0.683 [95% CI, 0.574&#8211;0.792]).</p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par59">Placenta previa is a leading cause of massive postpartum hemorrhage. A significant increase in severe postpartum hemorrhage has been reported with the increase in cesarean delivery worldwide and the incidence of placenta previa. Therefore, identifying the risk factors and developing a corresponding prediction model for intraoperative hemorrhage before delivery would allow for meticulous planning and multidisciplinary management of patients, substantially improving the perioperative prognosis. In recent years, multiple studies have demonstrated risk factors for postpartum hemorrhage and developed prediction nomogram or scoring models based on ultrasonic imaging or magnetic resonance imaging (MRI) characteristics in patients with placenta previa or placenta accrete spectrum disorder [<xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par60">Ultrasound examination is the most commonly used diagnostic modality for detecting abnormal placentation, and several signs indicative of placenta accrete spectrum disorder or intraoperative hemorrhage have been recommended including prominent lacunae, myometrial thinning, focal exophytic masses, bladder line interruption, increased vascularity [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In most recent years, MRI has been recommended as an adjunctive diagnostic modality and reserved for cases with inconclusive ultrasound findings. Several features indicative of massive hemorrhage on MRI include intraplacental dark bands with a random pattern on T2-weighted sequences, heterogeneous signal intensity in the placenta, focal uterine bulge, focal interruptions of the uterine wall, and tenting of the bladder [<xref ref-type="bibr" rid="CR19">19</xref>]. However, the predictive performance of both ultrasonography and MRI has mainly relied on the subjective interpretation of the &#8220;typical&#8221; signs, which largely depends on the experience and expertise of the sonographers and radiologists. Moreover, the absence of a standardized training program in imaging interpretation in developing countries further limits the extensive practice of previous predictive models, which commonly use different signs of ultrasonography combined with several clinical characteristics.</p><p id="Par61">This study established a postpartum hemorrhage prediction model for pregnancies with placenta previa totalis based on clinical characteristics and coagulation function indexes, which are particularly suitable for clinical use in developing countries where pregnancy monitoring systems are relatively deficient, including unavailability of accurate ultrasound evaluation by experienced ultrasound specialist and expensive MRI imaging. Univariate analysis in the development cohort revealed that gravidity, parity, number of prior cesarean deliveries, previous uterine surgery, immune disease, gestational age, antepartum bleeding, emergency cesarean, PLT, D-Dimer, APTT, fibrinogen, hemoglobin, were risk factors for postpartum hemorrhage. LASSO analysis selected three independent risk factors: the number of previous cesarean delivery, antepartum hemorrhage and fibrinogen. The prediction model yielded a positive predictive value (PPV) of 0.727 and 0.679, specificity of 0.707 and 0.595, as well as AUC of 0.721 and 0.706 in the development cohort and the test cohort, respectively. Furthermore, the developed nomogram allows for convenient use of the model in clinical practice.</p><p id="Par62">This study represents the first instance of developing a prediction model based on coagulation function indexes compared for postpartum hemorrhage in pregnant women with placenta previa. Previous studies have indicated a correlation between low fibrinogen concentration and platelet count with the incidence and severity of PPH [<xref ref-type="bibr" rid="CR20">20</xref>]. In our study, we focused on evaluating the coagulation function in pregnant women with placenta previa through standard coagulation tests, and we found that pregnant women with low plasma fibrinogen levels are at a higher risk of experiencing PPH. However, most current clinical laboratory coagulation index tests only provide reference values for non-pregnant women, lacking reference values for coagulation indexes during pregnancy [<xref ref-type="bibr" rid="CR21">21</xref>]. Thrombelastography, in comparison to laboratory coagulation assessments, offers increased sensitivity for detecting certain coagulation abnormalities. This improved sensitivity can assist in accurately identifying patients at a high risk of PPH in future clinical applications.</p><p id="Par63">The logistic regression model is widely employed in the field of medical research, making it a suitable choice for constructing a prediction model and developing a nomogram that can be conveniently used by clinicians. Machine learning technology is well-suited for identifying patterns within large datasets containing numerous variables, enabling the creation of prognostic models. Machine learning algorithms have demonstrated significantly better performance than conventional models for various medical conditions [<xref ref-type="bibr" rid="CR22">22</xref>], especially in medical image analysis. For this study, machine learning algorithms were used to train the models in the development cohort and verify their effectiveness in the test cohort. Among the machine learning-based models tested, the top five performers were selected. However, when compared to the conventional logistic regression model, the machine learning-based model did not exhibit superior performance. Previous studies have shown that classical models constructed using robust, manually chosen predictor variables can be comparable to data-driven models [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. This finding aligns with our results. While machine learning-based models outperformed in the development set, they were inferior in the test set, indicating a potential issue of overfitting in the model. To avoid overfitting, more data is needed for the training of machine learning models. Consequently, we anticipate conducting large-scale, multicenter clinical studies to develop a prediction model.</p><p id="Par64">The postpartum hemorrhage prediction model is highly applicable in various clinical scenarios, particularly in resource-limited settings. In prenatal clinics, obstetricians can use the model during routine antenatal visits to assess the risk of PPH in pregnant women with placenta previa totalis, enabling early identification of high-risk patients and facilitating timely interventions such as prophylactic uterotonics or blood product preparation. During hospital admissions for delivery, the model can guide clinicians in prioritizing high-risk cases for closer monitoring and emergency readiness. In remote or underserved areas, where access to advanced imaging like MRI or specialized ultrasound is limited, the model provides a practical alternative by relying on standard coagulation tests and clinical data. Additionally, the user-friendly nomogram can be integrated into telemedicine platforms, allowing healthcare providers in low-resource settings to consult with specialists and make informed decisions. By improving risk stratification and enabling proactive management, the model has the potential to significantly reduce PPH-related morbidity and mortality, particularly in developing countries.</p><p id="Par65">However, this study has several limitations. The retrospective design may introduce selection bias and unmeasured confounders. As a single-center study, generalizability may be limited. While the sample size was substantial, rare risk factors may not be fully captured. The model showed moderate discriminative ability (AUC 0.70), requiring external validation. Additionally, dynamic coagulation changes during delivery were not assessed. These limitations underscore the need for further research to improve the model's clinical applicability.</p></sec><sec id="Sec13"><title>Conclusion</title><p id="Par66">Our study aimed to develop and validate the model to predict PPH in women with PPT before cesarean delivery. Our three-variate nomogram, for the first time based on coagulation function indexes and objective clinical characteristics, provides clinicians with a convenient and accurate means of assessing the likelihood of PPH before surgery. By employing the prediction model, obstetricians can identify high-risk patients by the prediction model and prepare appropriate multi-disciplinary treatment strategies to reduce the occurrence of extensive blood loss. Therefore, it is worthy to conduct further large-scale prospective external validation studies to evaluate the clinical applicability of the three-variate-based model.</p></sec><sec id="Sec38" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="12884_2025_8066_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>PPH</term><def><p id="Par5">Postpartum hemorrhage</p></def></def-item><def-item><term>LASSO</term><def><p id="Par6">The least absolute shrinkage and selection operator</p></def></def-item><def-item><term>ROC</term><def><p id="Par7">Receiver operating characteristic</p></def></def-item><def-item><term>PP</term><def><p id="Par8">Placenta previa</p></def></def-item><def-item><term>PPT</term><def><p id="Par9">Placenta previa totalis</p></def></def-item><def-item><term>PAS</term><def><p id="Par10">Placenta accreta spectrum</p></def></def-item><def-item><term>MRI</term><def><p id="Par11">Magnetic resonance imaging</p></def></def-item><def-item><term>RBCs</term><def><p id="Par12">Red blood cells</p></def></def-item><def-item><term>CS</term><def><p id="Par13">Cesarean section</p></def></def-item><def-item><term>CD</term><def><p id="Par14">Cesarean delivery</p></def></def-item><def-item><term>IVF</term><def><p id="Par15">In-vitro fertilization</p></def></def-item><def-item><term>BMI</term><def><p id="Par16">Body mass index</p></def></def-item><def-item><term>PLT</term><def><p id="Par17">Platelet count</p></def></def-item><def-item><term>APTT</term><def><p id="Par18">Activated partial thromboplastin time</p></def></def-item><def-item><term>PT</term><def><p id="Par19">Prothrombin time</p></def></def-item><def-item><term>TT</term><def><p id="Par20">Thrombin time</p></def></def-item><def-item><term>FIB</term><def><p id="Par21">Fibrinogen</p></def></def-item><def-item><term>PBO</term><def><p id="Par22">Prophylactic balloon occlusion</p></def></def-item><def-item><term>AUC</term><def><p id="Par23">Area under curve</p></def></def-item><def-item><term>PPV</term><def><p id="Par24">Positive predictive value</p></def></def-item><def-item><term>DCA</term><def><p id="Par25">Decision curve analysis</p></def></def-item><def-item><term>NICU</term><def><p id="Par26">Neonatal intensive care unit</p></def></def-item><def-item><term>CIC</term><def><p id="Par27">Clinical impact curve</p></def></def-item><def-item><term>NPV</term><def><p id="Par28">Negative predictive value</p></def></def-item><def-item><term>PCA</term><def><p id="Par29">Principal component analysis</p></def></def-item><def-item><term>PCC</term><def><p id="Par30">Pearson correlation coefficient</p></def></def-item><def-item><term>ANOVA</term><def><p id="Par31">Analysis of variance</p></def></def-item><def-item><term>RFE</term><def><p id="Par32">Recursive feature elimination</p></def></def-item><def-item><term>KW</term><def><p id="Par33">Kruskal&#8211;Wallis test</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Shibin Hong, Chang Liu and Xin Kang contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We acknowledge the expert advice and some data support from interventional experts of Dr. Xuebin Zhang, and technical support of information collection from medical-record department of Mr. Rengang Li, Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.</p></ack><notes notes-type="author-contribution"><title>Authors' contribution</title><p>Conceived and designed the study: NZ, WD, LD; Collected data: SBH, XK, YPL, TZ; Analyzed data: SBH, CL, HTS; Figures preparation: SBH, CL, XK, HTS; Interpreted the results: CL, XK, YPL, LD, WD, NZ; Contributed to the writing of the manuscript: SBH, KUL, LD, WD, NZ. The author(s) read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by Natural Science Foundation of Science and Technology Commission of Shanghai Municipality (No. 22ZR1438700) and National Natural Science Foundation of China (NSFC) (82201846), Shanghai Municipal Health Commission (SMHC)(20224Y0019).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par67">This study was approved by the Ethics Committee of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (LY2022-055-B). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The requirement for informed consent was waived off by the Ethics Committee of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par68">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par69">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Say</surname><given-names>L</given-names></name><name name-style="western"><surname>Chou</surname><given-names>D</given-names></name><name name-style="western"><surname>Gemmill</surname><given-names>A</given-names></name><name name-style="western"><surname>Tun&#231;alp</surname><given-names>&#214;</given-names></name><name name-style="western"><surname>Moller</surname><given-names>A-B</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>J</given-names></name><name name-style="western"><surname>G&#252;lmezoglu</surname><given-names>AM</given-names></name><name name-style="western"><surname>Temmerman</surname><given-names>M</given-names></name><name name-style="western"><surname>Alkema</surname><given-names>L</given-names></name></person-group><article-title>Global causes of maternal death: a WHO systematic analysis</article-title><source>Lancet Glob Health</source><year>2014</year><volume>2</volume><fpage>e323</fpage><lpage>e333</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(14)70227-X</pub-id><pub-id pub-id-type="pmid">25103301</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Say L, Chou D, Gemmill A, Tun&#231;alp &#214;, Moller A-B, Daniels J, G&#252;lmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323&#8211;33. 10.1016/S2214-109X(14)70227-X.<pub-id pub-id-type="pmid">25103301</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2214-109X(14)70227-X</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bienstock</surname><given-names>JL</given-names></name><name name-style="western"><surname>Eke</surname><given-names>AC</given-names></name><name name-style="western"><surname>Hueppchen</surname><given-names>NA</given-names></name></person-group><article-title>Postpartum hemorrhage</article-title><source>N Engl J Med</source><year>2021</year><volume>384</volume><fpage>1635</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1513247</pub-id><pub-id pub-id-type="pmid">33913640</pub-id><pub-id pub-id-type="pmcid">PMC10181876</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Bienstock JL, Eke AC, Hueppchen NA. Postpartum hemorrhage. N Engl J Med. 2021;384:1635&#8211;45. 10.1056/NEJMra1513247.<pub-id pub-id-type="pmid">33913640</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMra1513247</pub-id><pub-id pub-id-type="pmcid">PMC10181876</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cahill</surname><given-names>AG</given-names></name><name name-style="western"><surname>Beigi</surname><given-names>R</given-names></name><name name-style="western"><surname>Heine</surname><given-names>RP</given-names></name><name name-style="western"><surname>Silver</surname><given-names>RM</given-names></name><name name-style="western"><surname>Wax</surname><given-names>JR</given-names></name></person-group><article-title>Placenta accreta spectrum</article-title><source>Am J Obstet Gynecol</source><year>2018</year><volume>219</volume><fpage>B2</fpage><lpage>B16</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2018.09.042</pub-id><pub-id pub-id-type="pmid">30471891</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219:B2&#8211;16. 10.1016/j.ajog.2018.09.042.<pub-id pub-id-type="pmid">30471891</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2018.09.042</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Guan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>He</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name></person-group><article-title>Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study</article-title><source>BMC Pregnancy Childbirth</source><year>2021</year><volume>21</volume><fpage>332</fpage><pub-id pub-id-type="doi">10.1186/s12884-021-03818-1</pub-id><pub-id pub-id-type="pmid">33902475</pub-id><pub-id pub-id-type="pmcid">PMC8077797</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Liu C, Yu F, Xu Y, Li J, Guan Z, Sun M, Liu C, He F, Chen D. Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study. BMC Pregnancy Childbirth. 2021;21:332. 10.1186/s12884-021-03818-1.<pub-id pub-id-type="pmid">33902475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-021-03818-1</pub-id><pub-id pub-id-type="pmcid">PMC8077797</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name></person-group><article-title>Combined efficacy of balloon occlusion and uterine artery embolization on coagulation function in patients with high-risk placenta previa during cesarean section</article-title><source>Int J Clin Pract</source><year>2022</year><volume>2022</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1155/2022/7750598</pub-id><pub-id pub-id-type="pmcid">PMC9159222</pub-id><pub-id pub-id-type="pmid">35685595</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Xu X, Zhu X. Combined efficacy of balloon occlusion and uterine artery embolization on coagulation function in patients with high-risk placenta previa during cesarean section. Int J Clin Pract. 2022;2022:1&#8211;6. 10.1155/2022/7750598.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/7750598</pub-id><pub-id pub-id-type="pmcid">PMC9159222</pub-id><pub-id pub-id-type="pmid">35685595</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>M</given-names></name><name name-style="western"><surname>Jin</surname><given-names>G</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Control of postpartum hemorrhage in women with placenta accreta spectrum using prophylactic balloon occlusion combined with pituitrin intra-arterial infusion</article-title><source>Eur Radiol</source><year>2020</year><volume>30</volume><fpage>4524</fpage><lpage>4533</lpage><pub-id pub-id-type="doi">10.1007/s00330-020-06813-w</pub-id><pub-id pub-id-type="pmid">32222796</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Dai M, Jin G, Lin J, Zhang Y, Chen Y, Zhou Q, Zhang X. Control of postpartum hemorrhage in women with placenta accreta spectrum using prophylactic balloon occlusion combined with pituitrin intra-arterial infusion. Eur Radiol. 2020;30:4524&#8211;33. 10.1007/s00330-020-06813-w.<pub-id pub-id-type="pmid">32222796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-020-06813-w</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Bao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Du</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Deng</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>W</given-names></name><name name-style="western"><surname>Feng</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Developing and validating nomogram to predict severe postpartum hemorrhage in women with placenta previa undergoing cesarean delivery: a multicenter retrospective case-control study</article-title><source>Front Med (Lausanne)</source><year>2021</year><volume>8</volume><fpage>789529</fpage><pub-id pub-id-type="doi">10.3389/fmed.2021.789529</pub-id><pub-id pub-id-type="pmid">35223881</pub-id><pub-id pub-id-type="pmcid">PMC8873861</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Dang X, Zhang L, Bao Y, Xu J, Du H, Wang S, Liu Y, Deng D, Chen S, Zeng W, Feng L, Liu H. Developing and validating nomogram to predict severe postpartum hemorrhage in women with placenta previa undergoing cesarean delivery: a multicenter retrospective case-control study. Front Med (Lausanne). 2021;8: 789529. 10.3389/fmed.2021.789529.<pub-id pub-id-type="pmid">35223881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2021.789529</pub-id><pub-id pub-id-type="pmcid">PMC8873861</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name></person-group><article-title>Ultrasound-based nomogram for postpartum hemorrhage prediction in pernicious placenta previa</article-title><source>Front Physiol</source><year>2022</year><volume>13</volume><fpage>982080</fpage><pub-id pub-id-type="doi">10.3389/fphys.2022.982080</pub-id><pub-id pub-id-type="pmid">36072853</pub-id><pub-id pub-id-type="pmcid">PMC9441797</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Zhou Y, Song Z, Wang X, Zhang M, Chen X, Zhang D. Ultrasound-based nomogram for postpartum hemorrhage prediction in pernicious placenta previa. Front Physiol. 2022;13: 982080. 10.3389/fphys.2022.982080.<pub-id pub-id-type="pmid">36072853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphys.2022.982080</pub-id><pub-id pub-id-type="pmcid">PMC9441797</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JY</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>EH</given-names></name><name name-style="western"><surname>Kang</surname><given-names>S</given-names></name><name name-style="western"><surname>Moon</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Jung</surname><given-names>SH</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SW</given-names></name><name name-style="western"><surname>Cho</surname><given-names>HY</given-names></name></person-group><article-title>Scoring model to predict massive post-partum bleeding in pregnancies with placenta previa: a retrospective cohort study</article-title><source>J Obstet Gynaecol Res</source><year>2018</year><volume>44</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1111/jog.13480</pub-id><pub-id pub-id-type="pmid">29067758</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Lee JY, Ahn EH, Kang S, Moon MJ, Jung SH, Chang SW, Cho HY. Scoring model to predict massive post-partum bleeding in pregnancies with placenta previa: a retrospective cohort study. J Obstet Gynaecol Res. 2018;44:54&#8211;60. 10.1111/jog.13480.<pub-id pub-id-type="pmid">29067758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jog.13480</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J-W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y-K</given-names></name><name name-style="western"><surname>Chin</surname><given-names>J-H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S-O</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M-Y</given-names></name><name name-style="western"><surname>Won</surname><given-names>H-S</given-names></name><name name-style="western"><surname>Choi</surname><given-names>W-J</given-names></name></person-group><article-title>Development of a scoring system to predict massive postpartum transfusion in placenta previa totalis</article-title><source>J Anesth</source><year>2017</year><volume>31</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1007/s00540-017-2365-8</pub-id><pub-id pub-id-type="pmid">28466102</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Kim J-W, Lee Y-K, Chin J-H, Kim S-O, Lee M-Y, Won H-S, Choi W-J. Development of a scoring system to predict massive postpartum transfusion in placenta previa totalis. J Anesth. 2017;31:593&#8211;600. 10.1007/s00540-017-2365-8.<pub-id pub-id-type="pmid">28466102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00540-017-2365-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>R</given-names></name><name name-style="western"><surname>Chu</surname><given-names>R</given-names></name><name name-style="western"><surname>Gao</surname><given-names>N</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Lan</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name></person-group><article-title>Development and validation of nomograms for predicting blood loss in placenta previa with placenta increta or percreta</article-title><source>Ann Transl Med</source><year>2021</year><volume>9</volume><fpage>287</fpage><pub-id pub-id-type="doi">10.21037/atm-20-5160</pub-id><pub-id pub-id-type="pmid">33708914</pub-id><pub-id pub-id-type="pmcid">PMC7944278</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Lu R, Chu R, Gao N, Li G, Tang H, Zhou X, Lan X, Li S, Zhang X, Xu Y, Ma Y. Development and validation of nomograms for predicting blood loss in placenta previa with placenta increta or percreta. Ann Transl Med. 2021;9:287. 10.21037/atm-20-5160.<pub-id pub-id-type="pmid">33708914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/atm-20-5160</pub-id><pub-id pub-id-type="pmcid">PMC7944278</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Z</given-names></name></person-group><article-title>A risk model to predict severe postpartum hemorrhage in patients with placenta previa: a single-center retrospective study</article-title><source>Ann Palliat Med</source><year>2019</year><volume>8</volume><fpage>611</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.21037/apm.2019.09.04</pub-id><pub-id pub-id-type="pmid">31594367</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Chen C, Liu X, Chen D, Huang S, Yan X, Liu H, Chang Q, Liang Z. A risk model to predict severe postpartum hemorrhage in patients with placenta previa: a single-center retrospective study. Ann Palliat Med. 2019;8:611&#8211;21. 10.21037/apm.2019.09.04.<pub-id pub-id-type="pmid">31594367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/apm.2019.09.04</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeBolt</surname><given-names>CA</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>HM</given-names></name><name name-style="western"><surname>Pruzan</surname><given-names>A</given-names></name><name name-style="western"><surname>Goldberger</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaplowitz</surname><given-names>E</given-names></name><name name-style="western"><surname>Buckley</surname><given-names>A</given-names></name><name name-style="western"><surname>Vieira</surname><given-names>L</given-names></name><name name-style="western"><surname>Stone</surname><given-names>J</given-names></name><name name-style="western"><surname>Bianco</surname><given-names>A</given-names></name></person-group><article-title>Patients with resolution of low-lying placenta and placenta previa remain at increased risk of postpartum hemorrhage</article-title><source>Ultrasound Obstet Gyne</source><year>2022</year><volume>60</volume><fpage>103</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1002/uog.24825</pub-id><pub-id pub-id-type="pmid">34826174</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">DeBolt CA, Rosenberg HM, Pruzan A, Goldberger C, Kaplowitz E, Buckley A, Vieira L, Stone J, Bianco A. Patients with resolution of low-lying placenta and placenta previa remain at increased risk of postpartum hemorrhage. Ultrasound Obstet Gyne. 2022;60:103&#8211;8. 10.1002/uog.24825.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/uog.24825</pub-id><pub-id pub-id-type="pmid">34826174</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nyfl&#248;t</surname><given-names>LT</given-names></name><name name-style="western"><surname>Sandven</surname><given-names>I</given-names></name><name name-style="western"><surname>Stray-Pedersen</surname><given-names>B</given-names></name><name name-style="western"><surname>Pettersen</surname><given-names>S</given-names></name><name name-style="western"><surname>Al-Zirqi</surname><given-names>I</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>AF</given-names></name><name name-style="western"><surname>Vangen</surname><given-names>S</given-names></name></person-group><article-title>Risk factors for severe postpartum hemorrhage: a case-control study</article-title><source>BMC Pregnancy Childbirth</source><year>2017</year><volume>17</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/s12884-016-1217-0</pub-id><pub-id pub-id-type="pmid">28068990</pub-id><pub-id pub-id-type="pmcid">PMC5223545</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Nyfl&#248;t LT, Sandven I, Stray-Pedersen B, Pettersen S, Al-Zirqi I, Rosenberg M, Jacobsen AF, Vangen S. Risk factors for severe postpartum hemorrhage: a case-control study. BMC Pregnancy Childbirth. 2017;17:17. 10.1186/s12884-016-1217-0.<pub-id pub-id-type="pmid">28068990</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-016-1217-0</pub-id><pub-id pub-id-type="pmcid">PMC5223545</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Analysis of risk factors for massive intraoperative bleeding in patients with placenta accreta spectrum</article-title><source>BMC Pregnancy Childbirth</source><year>2022</year><volume>22</volume><fpage>116</fpage><pub-id pub-id-type="doi">10.1186/s12884-022-04391-x</pub-id><pub-id pub-id-type="pmid">35148709</pub-id><pub-id pub-id-type="pmcid">PMC8832829</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Wang Y, Zhou Y, Zeng L, Chen L, Zhao Y. Analysis of risk factors for massive intraoperative bleeding in patients with placenta accreta spectrum. BMC Pregnancy Childbirth. 2022;22:116. 10.1186/s12884-022-04391-x.<pub-id pub-id-type="pmid">35148709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-022-04391-x</pub-id><pub-id pub-id-type="pmcid">PMC8832829</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ekin</surname><given-names>A</given-names></name><name name-style="western"><surname>Gezer</surname><given-names>C</given-names></name><name name-style="western"><surname>Solmaz</surname><given-names>U</given-names></name><name name-style="western"><surname>Taner</surname><given-names>CE</given-names></name><name name-style="western"><surname>Dogan</surname><given-names>A</given-names></name><name name-style="western"><surname>Ozeren</surname><given-names>M</given-names></name></person-group><article-title>Predictors of severity in primary postpartum hemorrhage</article-title><source>Arch Gynecol Obstet</source><year>2015</year><volume>292</volume><fpage>1247</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1007/s00404-015-3771-5</pub-id><pub-id pub-id-type="pmid">26041324</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Ekin A, Gezer C, Solmaz U, Taner CE, Dogan A, Ozeren M. Predictors of severity in primary postpartum hemorrhage. Arch Gynecol Obstet. 2015;292:1247&#8211;54. 10.1007/s00404-015-3771-5.<pub-id pub-id-type="pmid">26041324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00404-015-3771-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>A</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>The MRI estimations of placental thickness and cervical length correlate with postpartum hemorrhage (PPH) in patients with risk for placenta accreta spectrum (PAS) disorders</article-title><source>Placenta</source><year>2022</year><volume>126</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2022.06.016</pub-id><pub-id pub-id-type="pmid">35785692</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Lu T, Wang Y, Guo A, Deng Y, Wu C, Li X. The MRI estimations of placental thickness and cervical length correlate with postpartum hemorrhage (PPH) in patients with risk for placenta accreta spectrum (PAS) disorders. Placenta. 2022;126:76&#8211;82. 10.1016/j.placenta.2022.06.016.<pub-id pub-id-type="pmid">35785692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.placenta.2022.06.016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G</given-names></name></person-group><article-title>Feature explorer (FAE): a tool for developing and comparing radiomics models</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><fpage>e0237587</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0237587</pub-id><pub-id pub-id-type="pmid">32804986</pub-id><pub-id pub-id-type="pmcid">PMC7431107</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Song Y, Zhang J, Zhang Y, Hou Y, Yan X, Wang Y, Zhou M, Yao Y, Yang G. Feature explorer (FAE): a tool for developing and comparing radiomics models. PLoS ONE. 2020;15: e0237587. 10.1371/journal.pone.0237587.<pub-id pub-id-type="pmid">32804986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0237587</pub-id><pub-id pub-id-type="pmcid">PMC7431107</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srisajjakul</surname><given-names>S</given-names></name><name name-style="western"><surname>Prapaisilp</surname><given-names>P</given-names></name><name name-style="western"><surname>Bangchokdee</surname><given-names>S</given-names></name></person-group><article-title>Magnetic resonance imaging of placenta accreta spectrum: a step-by-step approach</article-title><source>Korean J Radiol</source><year>2021</year><volume>22</volume><fpage>198</fpage><pub-id pub-id-type="doi">10.3348/kjr.2020.0580</pub-id><pub-id pub-id-type="pmid">33169550</pub-id><pub-id pub-id-type="pmcid">PMC7817633</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Srisajjakul S, Prapaisilp P, Bangchokdee S. Magnetic resonance imaging of placenta accreta spectrum: a step-by-step approach. Korean J Radiol. 2021;22:198. 10.3348/kjr.2020.0580.<pub-id pub-id-type="pmid">33169550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3348/kjr.2020.0580</pub-id><pub-id pub-id-type="pmcid">PMC7817633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solomon</surname><given-names>C</given-names></name><name name-style="western"><surname>Collis</surname><given-names>RE</given-names></name><name name-style="western"><surname>Collins</surname><given-names>PW</given-names></name></person-group><article-title>Haemostatic monitoring during postpartum haemorrhage and implications for management</article-title><source>Br J Anaesth</source><year>2012</year><volume>109</volume><fpage>851</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1093/bja/aes361</pub-id><pub-id pub-id-type="pmid">23075633</pub-id><pub-id pub-id-type="pmcid">PMC3498756</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012;109:851&#8211;63. 10.1093/bja/aes361.<pub-id pub-id-type="pmid">23075633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/aes361</pub-id><pub-id pub-id-type="pmcid">PMC3498756</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>QD</given-names></name><name name-style="western"><surname>Wei</surname><given-names>YM</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>WR</given-names></name><name name-style="western"><surname>Gu</surname><given-names>YY</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>HX</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name></person-group><article-title>Comparison of four-coagulation-tests values in normal pregnant women during early and late pregnancy and the influence of age</article-title><source>Zhonghua Fu Chan Ke Za Zhi</source><year>2022</year><volume>57</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.3760/cma.j.cn112141-20220331-00204</pub-id><pub-id pub-id-type="pmid">36299176</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zhang QD, Wei YM, Liu C, Qiao WR, Gu YY, Zhao HX, Yang H. Comparison of four-coagulation-tests values in normal pregnant women during early and late pregnancy and the influence of age. Zhonghua Fu Chan Ke Za Zhi. 2022;57:740&#8211;5. 10.3760/cma.j.cn112141-20220331-00204.<pub-id pub-id-type="pmid">36299176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3760/cma.j.cn112141-20220331-00204</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name><name name-style="western"><surname>Fung</surname><given-names>K-M</given-names></name><name name-style="western"><surname>Thai</surname><given-names>TC</given-names></name><name name-style="western"><surname>Moore</surname><given-names>K</given-names></name><name name-style="western"><surname>Mannel</surname><given-names>RS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y</given-names></name></person-group><article-title>Recent advances and clinical applications of deep learning in medical image analysis</article-title><source>Med Image Anal</source><year>2022</year><volume>79</volume><fpage>102444</fpage><pub-id pub-id-type="doi">10.1016/j.media.2022.102444</pub-id><pub-id pub-id-type="pmid">35472844</pub-id><pub-id pub-id-type="pmcid">PMC9156578</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chen X, Wang X, Zhang K, Fung K-M, Thai TC, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Recent advances and clinical applications of deep learning in medical image analysis. Med Image Anal. 2022;79: 102444. 10.1016/j.media.2022.102444.<pub-id pub-id-type="pmid">35472844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.media.2022.102444</pub-id><pub-id pub-id-type="pmcid">PMC9156578</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>NS-E</given-names></name><name name-style="western"><surname>Tomizawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Choi</surname><given-names>AY</given-names></name><name name-style="western"><surname>Hernandez-Boussard</surname><given-names>T</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>JH</given-names></name></person-group><article-title>A comparison of logistic regression against machine learning algorithms for gastric cancer risk prediction within real-world clinical data streams</article-title><source>JCO Clin Cancer Inf</source><year>2022</year><volume>6</volume><fpage>e2200039</fpage><pub-id pub-id-type="doi">10.1200/CCI.22.00039</pub-id><pub-id pub-id-type="pmcid">PMC9259116</pub-id><pub-id pub-id-type="pmid">35763703</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Huang RJ, Kwon NS-E, Tomizawa Y, Choi AY, Hernandez-Boussard T, Hwang JH. A comparison of logistic regression against machine learning algorithms for gastric cancer risk prediction within real-world clinical data streams. JCO Clin Cancer Inf. 2022;6:e2200039. 10.1200/CCI.22.00039.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/CCI.22.00039</pub-id><pub-id pub-id-type="pmcid">PMC9259116</pub-id><pub-id pub-id-type="pmid">35763703</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Austin</surname><given-names>DE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DS</given-names></name><name name-style="western"><surname>Wang</surname><given-names>CX</given-names></name><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Porter</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure</article-title><source>Int J Cardiol</source><year>2022</year><volume>365</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2022.07.035</pub-id><pub-id pub-id-type="pmid">35868354</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Austin DE, Lee DS, Wang CX, Ma S, Wang X, Porter J, Wang B. Comparison of machine learning and the regression-based EHMRG model for predicting early mortality in acute heart failure. Int J Cardiol. 2022;365:78&#8211;84. 10.1016/j.ijcard.2022.07.035.<pub-id pub-id-type="pmid">35868354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijcard.2022.07.035</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>